|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Isopropyl glycidyl ether | CAS 4016-14-2 | ||
| C6H12O2 | RTECS TZ3500000 | ||
|
Synonyms & Trade Names 1,2-Epoxy-3-isopropoxypropane; IGE; Isopropoxymethyl oxirane |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: C 50 ppm (240 mg/m3) [15-minute] | ||
| OSHA PEL�: TWA 50 ppm (240 mg/m3) | |||
| IDLH 400 ppm | Conversion 1 ppm = 4.75 mg/m3 | ||
|
Physical Description Colorless liquid. |
|||
|
MW: 116.2 |
BP: 279°F |
FRZ: ? |
Sol: 19% |
|
VP(77°F): 9 mmHg |
IP: ? |
|
Sp.Gr: 0.92 |
|
Fl.P: 92°F |
UEL: ? |
LEL: ? |
|
| Class IC Flammable Liquid: Fl.P. at or above 73�F and below 100�F. | |||
|
Incompatibilities & Reactivities Strong oxidizers, strong caustics [Note: May form explosive peroxides upon exposure to air or light.] |
|||
|
Measurement Methods NIOSH 1620; OSHA 7 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet (flammable) Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH/OSHA Up to 400 ppm: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode�/(APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, upper respiratory system; skin sensitization; possible hematopoietic, reproductive effects | |
|
Target Organs
Eyes, skin, respiratory system, blood, reproductive system |
|
| See also: INTRODUCTION |